“Medicare doesn't need to cover Ozempic. Medicare needs to take Ozempic.” Cato’s @mfcannon told @AJEnglish that the real path to affordable GLP-1 drugs isn’t government subsidies, but eliminating cost-increasing regulation.
Let price competition work, and people won't need government subsidies.
Video